Market Tracker

12/02 1:01pm ET

Hemispherx Biopharma Inc (NYSE MKT LLC:HEB)

0.792
Delayed Data
As of 12:43pm ET
 -0.0285 / -3.47%
Today’s Change
0.72
Today|||52-Week Range
2.64
-18.01%
Year-to-Date
No recent news for Hemispherx Biopharma Inc.

Today’s Trading

Previous close0.82
Today’s open0.81
Day’s range0.79 - 0.82
Volume53,918
Average volume (3 months)136,862
Market cap$19.8M
Dividend yield--
Data as of 12:43pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)+33.33%
Earnings growth (this year)--
Earnings growth (next 5 years)+35.00%
Revenue growth (last year)-32.49%
P/E ratioNM
Price/Sales1,715.21
Price/Book0.83

Competitors

 Today’s
change
Today’s
% change
ONTXOnconova Therapeutic...-0.04-1.40%
MRNSMarinus Pharmaceutic...+0.03+2.91%
VKTXViking Therapeutics ...+0.03+2.94%
BLPHBellerophon Therapeu...-0.10-16.67%
Data as of 12:56pm ET, 12/02/2016

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$133.0K
Annual profit (last year)-$15.2M
Net profit margin-11,451.13%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Secretary
Thomas Kenwood Equels
Senior Vice President-
Operations
Wayne S. Springate
Corporate headquarters
Philadelphia, Pennsylvania

Forecasts